Search

Patricia L Morris

Examiner (ID: 4560, Phone: (571)272-0688 , Office: P/1625 )

Most Active Art Unit
1625
Art Unit(s)
1203, 1612, 1201, 1625, 1209
Total Applications
3798
Issued Applications
2697
Pending Applications
142
Abandoned Applications
965

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 14684815 [patent_doc_number] => 20190241522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-08 [patent_title] => NICOTINIC ACID OR ISONICOTINIC ACID COMPOUND AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/317114 [patent_app_country] => US [patent_app_date] => 2017-09-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4319 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16317114 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/317114
Nicotinic acid or isonicotinic acid compound and use thereof Sep 7, 2017 Issued
Array ( [id] => 13702483 [patent_doc_number] => 20170362196 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-12-21 [patent_title] => SUBSTITUTED BENZOTHIOPHENYL DERIVATIVES AS GPR40 AGONISTS FOR THE TREATMENT OF TYPE II DIABETES [patent_app_type] => utility [patent_app_number] => 15/697867 [patent_app_country] => US [patent_app_date] => 2017-09-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 40536 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15697867 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/697867
Substituted benzothiophenyl derivatives as GPR40 agonists for the treatment of type II diabetes Sep 6, 2017 Issued
Array ( [id] => 15245167 [patent_doc_number] => 10508096 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-12-17 [patent_title] => Nicotine salts, co-crystals, and salt co-crystal complexes [patent_app_type] => utility [patent_app_number] => 15/695227 [patent_app_country] => US [patent_app_date] => 2017-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 22 [patent_no_of_words] => 20637 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15695227 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/695227
Nicotine salts, co-crystals, and salt co-crystal complexes Sep 4, 2017 Issued
Array ( [id] => 14119143 [patent_doc_number] => 10246416 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-04-02 [patent_title] => Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides [patent_app_type] => utility [patent_app_number] => 15/692255 [patent_app_country] => US [patent_app_date] => 2017-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11925 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15692255 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/692255
Process for preparing [(3-hydroxypyridine-2-carbonyl)amino] alkanoic acids, esters and amides Aug 30, 2017 Issued
Array ( [id] => 15993273 [patent_doc_number] => 20200172507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-06-04 [patent_title] => CRYSTALS OF CYCLIC AMINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/326580 [patent_app_country] => US [patent_app_date] => 2017-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8879 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16326580 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/326580
Crystals of cyclic amine derivative and pharmaceutical use thereof Aug 24, 2017 Issued
Array ( [id] => 13079225 [patent_doc_number] => 10059670 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2018-08-28 [patent_title] => Synthesis of 2-carboxamide cycloamino urea derivatives [patent_app_type] => utility [patent_app_number] => 15/684419 [patent_app_country] => US [patent_app_date] => 2017-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6993 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 251 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15684419 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/684419
Synthesis of 2-carboxamide cycloamino urea derivatives Aug 22, 2017 Issued
Array ( [id] => 12884896 [patent_doc_number] => 20180186807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-05 [patent_title] => COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN [patent_app_type] => utility [patent_app_number] => 15/680794 [patent_app_country] => US [patent_app_date] => 2017-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13063 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 287 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15680794 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/680794
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN Aug 17, 2017 Abandoned
Array ( [id] => 12151443 [patent_doc_number] => 20180022708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-25 [patent_title] => 'PROCESSES FOR PREPARING ASK1 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 15/680024 [patent_app_country] => US [patent_app_date] => 2017-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 29449 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15680024 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/680024
Processes for preparing ASK1 inhibitors Aug 16, 2017 Issued
Array ( [id] => 12205779 [patent_doc_number] => 20180051005 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-02-22 [patent_title] => 'THERAPEUTIC COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 15/680041 [patent_app_country] => US [patent_app_date] => 2017-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 39467 [patent_no_of_claims] => 88 [patent_no_of_ind_claims] => 64 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15680041 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/680041
Therapeutic compounds Aug 16, 2017 Issued
Array ( [id] => 15483095 [patent_doc_number] => 10556880 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-02-11 [patent_title] => Nicotine salts, co-crystals, and salt co-crystal complexes [patent_app_type] => utility [patent_app_number] => 15/671722 [patent_app_country] => US [patent_app_date] => 2017-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 25 [patent_no_of_words] => 25561 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15671722 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/671722
Nicotine salts, co-crystals, and salt co-crystal complexes Aug 7, 2017 Issued
Array ( [id] => 16564242 [patent_doc_number] => 10889600 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-01-12 [patent_title] => Boron-containing compounds [patent_app_type] => utility [patent_app_number] => 16/322372 [patent_app_country] => US [patent_app_date] => 2017-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18608 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 127 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322372 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/322372
Boron-containing compounds Aug 2, 2017 Issued
Array ( [id] => 14684915 [patent_doc_number] => 20190241572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-08 [patent_title] => GALUNISERTIB CRYSTALLINE FORM, PREPARATION METHOD THEREOF AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/315242 [patent_app_country] => US [patent_app_date] => 2017-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3650 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315242 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/315242
Galunisertib crystalline form, preparation method thereof and use thereof Jul 20, 2017 Issued
Array ( [id] => 14684915 [patent_doc_number] => 20190241572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-08 [patent_title] => GALUNISERTIB CRYSTALLINE FORM, PREPARATION METHOD THEREOF AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/315242 [patent_app_country] => US [patent_app_date] => 2017-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3650 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315242 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/315242
Galunisertib crystalline form, preparation method thereof and use thereof Jul 20, 2017 Issued
Array ( [id] => 14684915 [patent_doc_number] => 20190241572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-08 [patent_title] => GALUNISERTIB CRYSTALLINE FORM, PREPARATION METHOD THEREOF AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/315242 [patent_app_country] => US [patent_app_date] => 2017-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3650 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315242 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/315242
Galunisertib crystalline form, preparation method thereof and use thereof Jul 20, 2017 Issued
Array ( [id] => 14684915 [patent_doc_number] => 20190241572 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-08 [patent_title] => GALUNISERTIB CRYSTALLINE FORM, PREPARATION METHOD THEREOF AND USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/315242 [patent_app_country] => US [patent_app_date] => 2017-07-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3650 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315242 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/315242
Galunisertib crystalline form, preparation method thereof and use thereof Jul 20, 2017 Issued
Array ( [id] => 16169432 [patent_doc_number] => 10710980 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-07-14 [patent_title] => Aminopyridine derivatives and their use as selective ALK-2 inhibitors [patent_app_type] => utility [patent_app_number] => 16/318250 [patent_app_country] => US [patent_app_date] => 2017-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 19 [patent_no_of_words] => 31969 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16318250 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/318250
Aminopyridine derivatives and their use as selective ALK-2 inhibitors Jul 17, 2017 Issued
Array ( [id] => 12138181 [patent_doc_number] => 20180016264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-18 [patent_title] => 'SALT FORMS OF 4-CYANO-N-(2-(4,4-DIMETHYLCYCLOHEX-1-EN-1-YL)-6-(2,2,6,6-TETRAMETHYLTETRAHYDRO-2H-PYRAN-4-YL)PYRIDIN-3-YL)-1H-IMIDAZOLE-2-CARBOXAMIDE' [patent_app_type] => utility [patent_app_number] => 15/651829 [patent_app_country] => US [patent_app_date] => 2017-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 8125 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15651829 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/651829
Salt forms of 4-cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide Jul 16, 2017 Issued
Array ( [id] => 12001713 [patent_doc_number] => 20170305864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-10-26 [patent_title] => 'HETEROCYCLIC COMPOUNDS AS PESTICIDES' [patent_app_type] => utility [patent_app_number] => 15/645814 [patent_app_country] => US [patent_app_date] => 2017-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 187140 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15645814 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/645814
Heterocyclic compounds as pesticides Jul 9, 2017 Issued
Array ( [id] => 12126198 [patent_doc_number] => 20180009785 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-01-11 [patent_title] => 'SUBSTITUTED HYDANTOIN AND THIOHYDANTOIN DERIVATIVES AS ANDROGEN RECEPTOR ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 15/643979 [patent_app_country] => US [patent_app_date] => 2017-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30392 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15643979 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/643979
SUBSTITUTED HYDANTOIN AND THIOHYDANTOIN DERIVATIVES AS ANDROGEN RECEPTOR ANTAGONISTS Jul 6, 2017 Abandoned
Array ( [id] => 14684821 [patent_doc_number] => 20190241525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-08 [patent_title] => METHODS FOR THE SYNTHESIS OF DEUTERATED DEXTROMETHORPHAN [patent_app_type] => utility [patent_app_number] => 16/312439 [patent_app_country] => US [patent_app_date] => 2017-07-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20613 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16312439 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/312439
Methods for the synthesis of deuterated dextromethorphan Jul 2, 2017 Issued
Menu